Cargando…

The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination

Detalles Bibliográficos
Autores principales: Shi, Rui, Chai, Yan, Duan, Xiaomin, Bi, Xiaoshan, Huang, Qingrui, Wang, Qihui, Tan, Shuguang, Gao, George F., Zhu, Jianhua, Yan, Jinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058617/
https://www.ncbi.nlm.nih.gov/pubmed/32296041
http://dx.doi.org/10.1038/s41392-020-0121-2
_version_ 1783503892380647424
author Shi, Rui
Chai, Yan
Duan, Xiaomin
Bi, Xiaoshan
Huang, Qingrui
Wang, Qihui
Tan, Shuguang
Gao, George F.
Zhu, Jianhua
Yan, Jinghua
author_facet Shi, Rui
Chai, Yan
Duan, Xiaomin
Bi, Xiaoshan
Huang, Qingrui
Wang, Qihui
Tan, Shuguang
Gao, George F.
Zhu, Jianhua
Yan, Jinghua
author_sort Shi, Rui
collection PubMed
description
format Online
Article
Text
id pubmed-7058617
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70586172020-03-19 The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination Shi, Rui Chai, Yan Duan, Xiaomin Bi, Xiaoshan Huang, Qingrui Wang, Qihui Tan, Shuguang Gao, George F. Zhu, Jianhua Yan, Jinghua Signal Transduct Target Ther Letter Nature Publishing Group UK 2020-03-06 /pmc/articles/PMC7058617/ /pubmed/32296041 http://dx.doi.org/10.1038/s41392-020-0121-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Shi, Rui
Chai, Yan
Duan, Xiaomin
Bi, Xiaoshan
Huang, Qingrui
Wang, Qihui
Tan, Shuguang
Gao, George F.
Zhu, Jianhua
Yan, Jinghua
The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
title The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
title_full The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
title_fullStr The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
title_full_unstemmed The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
title_short The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
title_sort identification of a cd47-blocking “hotspot” and design of a cd47/pd-l1 dual-specific antibody with limited hemagglutination
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058617/
https://www.ncbi.nlm.nih.gov/pubmed/32296041
http://dx.doi.org/10.1038/s41392-020-0121-2
work_keys_str_mv AT shirui theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT chaiyan theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT duanxiaomin theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT bixiaoshan theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT huangqingrui theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT wangqihui theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT tanshuguang theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT gaogeorgef theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT zhujianhua theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT yanjinghua theidentificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT shirui identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT chaiyan identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT duanxiaomin identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT bixiaoshan identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT huangqingrui identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT wangqihui identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT tanshuguang identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT gaogeorgef identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT zhujianhua identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination
AT yanjinghua identificationofacd47blockinghotspotanddesignofacd47pdl1dualspecificantibodywithlimitedhemagglutination